InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: StocksAnonymous post# 75164

Wednesday, 04/29/2015 1:57:06 PM

Wednesday, April 29, 2015 1:57:06 PM

Post# of 80868
Brad's as well as your expectations seem to be very optimistic.

My expectation is that the company will sell for $170 to $195 million this year, with only q3 and q4 surpassing last year's revenue numbers.

The stock price will remain undervalued regardless....as there is no way it cannot break even and post minor profits with sales above $170 million per year, regardless of endorsements.

Revenues are under pressure because of protein spiking chatter, the complete lack of exciting and engaging communication and because BB.com is guiding traffic away from Musclepharm products towards Glanbia, Cellucor and new brands....hurting the growth in the short term.

The company has done a lot of right things, but lately it has gotten a little introvert and defensive in it's communication, which has made it drop a little bit in popularity among some customers and partners.

Right now, a realistic price target is $9.5....if Brad really delivered what was promised, hell the stock price would be $20....